What did the pandemic do to healthtech investing? | Marissa Bertorelli (Principal at Polaris Partners‪)‬ The Data Minute

Even in turbulent times, early-stage investing has held up in one particular area: Healthcare. In fact: Biotech, pharmaceutical, and digital therapeutic startups are receiving more capital now than before the pandemic, in 2018 - 2019.In this week’s episode of The Data Minute, join Peter Walker (Head of Insights at Carta) as he sits down with Marissa Bertorelli (Principal, Polaris Partners) for an illuminating conversation around trends they're seeing in early-stage healthcare investing.In a w...